NAMS
NewAmsterdam Pharma·NASDAQ
--
--(--)
--
--(--)
5.81 / 10
Netural
Analyst sentiment is bullish with two strong‑buy ratings, though one analyst shows 0% historical win rate and the other 40%. Fund‑flow rating is excellent (8.04/10) and capital inflows are positive, but the stock price is down 5.95%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-19
InstitutionGuggenheim
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of NAMS?
- NAMS holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.81/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
